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ABSTRACT
Diadenosine polyphosphates are a family of dinucleotides with
relevant properties in the eye and in other tissues. Diadenosine
polyphosphates can activate P2Y and P2X receptors present on
the ocular surface, anterior segment and retina. In the cornea, the
presence of a P2Y2, P2Y4 and P2Y6 receptor has been identified. Both
diadenosine polyphosphates and other purinergic agonists modified
corneal wound healing depending on the receptor that is activated by
these substances. To confirm the involvement of the P2Y2 receptor in
the wound healing process after the challenge with Ap4A, we have
designed siRNA against P2Y2 receptor. We have observed that P2Y2 is
localized in the most external layer of the corneal epithelium. The pre-
treatment with siRNA produced a disappearance of the receptor at 12
and 24 hours after the wound, being the location for P2Y2 restored 36
hours after the wound. We have also observed that in half of the tested
corneas, there was an increase in the P2Y2 expression after silencing
compared to control and Ap4A treated corneas, being this receptor
localized both in corneal epithelium and stroma.
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RESUMEN
Sobreexpresión del receptor P2Y2 tras su silenciamiento
durante el proceso de cicatrización corneal
Los diadenosina polifosfatos son una familia de dinucleótidos con
gran relevancia en las propiedades del ojo y de otros tejidos. Estos
diadenosina polifosfatos pueden activar los receptores P2Y y P2X pre-
sentes en la superficie ocular, en el segmento anterior y en la retina.
En la cornea, se ha identificado la presencia de receptores P2Y2, P2Y4
y P2Y6. Tanto los diadenosina polifosfatos como los receptores puri-
nérgicos modifican el proceso de cicatrización corneal dependiendo
del tipo de receptor activado por los distintos dinucleótidos. Para lo-
calizar el receptor P2Y2 en córneas lesionadas y tratadas con Ap4A
en presencia o ausencia de un siRNA para el receptor P2Y2, hemos
realizado un ensayo de inmunohistoquímica. Hemos observado que
el receptor P2Y2 se localiza en el epitelio tras la lesión corneal y el con-
secuente tratamiento con Ap4A. El pre-tratamiento con el siRNA pro-
duce la desaparición de la señal para este receptor tanto a las 12 como
a las 24 horas de la lesión corneal, siendo la localización de este re-
ceptor P2Y2 recuperada a las 36 horas de la lesión en presencia del
siRNA. Además, hemos observado que en la mitad de las córneas ana-
lizadas, existía un incremento en la expresión del receptor P2Y2 tras
el silenciamiento del mismo comparado con las córneas control y con
las tratadas con Ap4A, localizando la presencia de este receptor tanto
en el epitelio como en el estroma corneal.
Palabras clave: Ap4A; P2Y2; siRNA; Cicatrización corneal.
1. INTRODUCTION
The cornea is one of the most important components of the
optical pathway. It is a multilayered tissue characterized by its
transparency, avascularity, the ability to refract light and to filter out
incoming ultraviolet radiation. Within the five layers that compound
the cornea —epithelium, Bowman’s membrane, stroma, Descemet’s
membrane and endothelium— the epithelium is the outer layer and
the one that is easily damaged due to diverse factors. These include
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the entry of a foreign body, any traumatic process, a defect in contact
lenses or the use of refractive surgery to correct refractive alterations.
When this happens, a process named corneal wound healing
starts to regenerate normal epithelium in order to maintain the
correct refraction of light. Corneal wound healing involved three
consecutive phases that are part of a continuous process. Animal
studies have shown that these three stages are: lag phase (from
0 hours to 10 hours after the wound), cell migration (until 24 to
36 hours after the wound) and cell proliferation (lasting from 24-36
hours after the wound to weeks) (1).
There are many substances present in tears, aqueous humour or
released from corneal nerves, that modified the wound healing
process after ocular surface injuries (2, 3). Within these molecules
we find nucleotides and dinucleotides (3, 4). In our previous works
we demonstrated that the dinucleotides can modify rate of corneal
re-epithelialization in New Zealand White Rabbits both in vivo and
in vitro (3, 5). We have demonstrated, both pharmacologically and
with the used of the RNA interference (RNAi) technology, that Ap4A
produces acceleration in the rate of corneal re-epithelialization by
stimulating to P2Y2 receptors. On the contrary other dinucleotides,
Ap3A and Ap5A exert the opposite effect delaying corneal re-
epithelialization by binding to a P2Y6 receptor (5, 6).
The aim of this manuscript is to describe the presence of the
P2Y2 receptor in the cornea and to see the effect of a siRNA against
the P2Y2 receptor in the presence and in the absence of Ap4A.
2. MATERIALS AND METHODS
2.1. Animals
Male, adult New Zealand White Rabbits were used. All the animals
were kept in individual cages with free access to food and water, under
controlled cycles (12 hours light:12 hours dark), and the experimental
procedures were carried out in accordance with the ARVO Statement
for the Use of Animals in Ophthalmic and Vision Research, and the
European Communities Council Directive (89/609/EEC).
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2.2. P2Y2 silencing
To design P2Y2 receptor-specific siRNA duplexes, rabbit P2Y2
receptor coding sequence (GenBank accession number EU886321)
was submitted to the Ambion siRNA target Finder website (http://
www.ambion.com/techlib/misc/siRNA_finder.html) for siRNA
prediction. One sequence of nine (max. GC content 60%) suggested
candidates was selected (6). Nucleotide sequence of the siRNA target
sites was as follows: P2Y2 siRNA #2, 5’-AACCTGTACTGCAGCATCCTC-
3’. This siRNAs was obtained from Applied Biosystems, in annealed
and lyophilized forms and were suspended in 0.9% NaCl before in
vivo use.
2.3. In vivo delivery of P2Y2 siRNA and wounding procedure
The siRNA was applied in one single eye in 10 nmol 0.9% NaCl
drops (volume instilled 40 μl) along four consecutive days. The
contralateral eye received the same volume of saline solution (0.9%
NaCl). Slit-lamp biomicroscopy was performed during instillation
process to evaluate possible changes in the cornea.
Corneal wounds were performed 10 hours before the fourth siR-
NA instillation. After topical anaesthesia (0.4% oxibuprocaine and 1%
tetracaine, Alcon Cusi, Barcelona, Spain), corneal wound were made
to the epithelium of both eyes by applying a 5-mm disc of Whatman
no. 1 paper soaked in n-heptanol (Sigma-Aldrich, St. Louis, MO) as
previously described (3). Briefly, discs were place in the centre of the
cornea and left there for 30 seconds (7) and after removal of the disc,
the eyes were washed with isotonic saline solution.
Ap4A treatment was performed every six hours as described
previously (3).
2.4. Immunohistochemistry
12, 24 and 36 hours after epithelium wounding (72, 84 and 96
hours after the first siRNA instillation), rabbits were euthanized with
sodium pentothal and eyes were enucleated. Corneas were dissected
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and fixed with 4% paraformaldehyde in PBS 0.15M at 4 ºC for 6
hours. After fixation, corneas were embedded in Jung Tissue Freezing
Medium (Leica Microsystems, Barcelona, Spain) and 10 μm sections
were done. P2Y2 immunocytochemical assay was performed as
previously described for cells. Briefly, sections were permeabilized
with blocking solution (PBS 1X BSA 3% Triton X-100 FBS 5%) for
1 hour to block the non-specific binding, and after washing with
PBS 1X BSA 3%, sections are incubated with primary goat polyclonal
anti-P2Y2 (1:50) or PBS 1X BSA 3% for negative controls overnight
at 4 ºC. Sections were washed twice in PBS 1X BSA 3% and
incubated with the secondary antibody donkey anti-goat IgG-FITC
(1:200) for 1 hour at room temperature. Finally, after washing in
PBS 1X slices were mounting with Vectashield mounting medium
and observed under confocal microscope (Axiovert 200M; Carl Zeiss
Meditec GmbH, Jena, Germany), equipped with a Pascal confocal
module (LSM 5; Zeiss). All images were managed with the
accompanying Pascal software.
3. RESULTS
3.1. P2Y2 location in the cornea
Immunocytochemical analysis for P2Y2 in the cornea reveals that
this receptor is mainly localized in the outer layer of the epithelium
(Figure 1), while the inner layers of the epithelium are barely
marked. We have not found any P2Y2 signal in the other layers of the
cornea, neither in the stroma nor in the endothelium.
3.2. Inhibition of P2Y2 receptor expression by siRNA
After performing the treatments described in Methods, corneas
were wounded and the effect of the siRNA against the P2Y2 receptor
was tested by immunohystochemical analysis 12, 24 and 36 hours
after the healing (72, 84 and 96 hours after the first siRNA instilla-
tion). As we can observe, after the corneas were wounded, the P2Y2
receptor was still localized in the outer layer of the epithelium, being
this signal higher in control corneas than in Ap4A treated corneas,
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both at 12 and 24 hours after wounding (Figure 2A and 2B). 36
hours after the wounds were performed, P2Y2 staining was similar
in the three different treatments, including the siRNA treated
corneas, revealing a full recovery of the P2Y2 receptor (Figure 2C).
These results indicate that silencing the P2Y2 receptor in our
model was detected 12 hours after the wound was performed.
Nevertheless, P2Y2 receptor signal was again visible 36 hours after
the wound had been made.
Figure 1. P2Y2 receptor location in the cornea. Immunocytochemical analysis
for the P2Y2 in the cornea revealing the presence of the P2Y2 receptor in the corneal
epithelium (green fluorescence by FITC). Image managed with the Pascal software
of the Axiovert 200M confocal microscope at 40X magnification.
3.3. Over-expression of P2Y2 receptor after silencing
In half of the siRNA treated corneas, and 36 hours after the
wounding (96 hours after the first siRNA instillation), we have
observed an increase in the expression of P2Y2 receptors compared
with control and Ap4A (Figure 3). In this case, the P2Y2 signal was
not constrained to the outer layer of the epithelium, and it was
possible to localize P2Y2 receptors in the whole epithelium and in
the stroma (Figure 3).
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Figure 2. P2Y2 immunostaining of treated corneas after wound. (A) A series
of micrographs showing the P2Y2 signal in corneas treated with saline 0.9%, Ap4A
100 μM and siRNA + Ap4A 100 μM, 12 hours after wound. (B) Immunostaining for
P2Y2 in treated corneas 24 hours after the wound. (C) A series of micrographs
showing the P2Y2 signal in corneas treated with saline 0.9%, Ap4A 100 μM and
siRNA + Ap4A 100 μM, 36 hours after wound. Green fluorescence (FITC) localizes
P2Y2 receptor while in blue we can observe the nuclear staining for DAPI. Images
are managed at a magnification of 40X.
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4. DISCUSSION
As we have previously mentioned, the cornea is formed by five
to six different layers, including the outer one, the epithelium. The
distribution of the purinergic receptors present in the cornea revealed
that P2Y1, P2Y2, P2Y4 and P2Y6 receptor are present this part of the
eye (8).
The present experimental work confirms the location of the P2Y2
receptor after corneal wound healing and how when using a siRNA
against this receptor there is an initial disappearance of the receptor
followed by an over-expression of this protein.
The presence of the P2Y2 receptor in the epithelium is related
to the ability of some nucleotides to increase the rate of re-
epithelialization after a corneal wound (6). The involvement of
metabotropic P2 receptors in corneal wound healing has been also
reported by other groups and in all the cases the different researchers
report that ATP, UTP and Ap4A accelerate the rate of healing (9-11).
Our IHC results reveal that after wounded, the P2Y2 staining in
Ap4A treated lessons is less intense that in control wounds. As happens
Figure 3. Over-expression of P2Y2 receptor after silencing. Immunostaining
for P2Y2 36 hours after wound (96 hours after the first siRNA instillation) where
we can observed an increase in P2Y2 expression after siRNA instillation compared
with control and Ap4A treated corneas. Green fluorescence (FITC) localizes P2Y2
receptor while in blue we can observe the nuclear staining for DAPI. Images are
managed at a magnification of 40X.
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with many other agonists (for example insulin), when Ap4A binds to
its receptor P2Y2 on the cell surface, the Ap4A-P2Y2 complex undergoes
down-regulation and presumably endocytosis and is subsequently
intracellular lysosomal/proteosomal degradation (12, 13). This down-
regulatory mechanism together with the receptor rate of synthesis
permits to maintain a minimal number of P2Y2 receptor on epithelial
cell surface. This is absolutely relevant since in case that an injury
occur the cornea needs to trigger the wound healing mechanism to
keep this ocular structure perfectly transparent.
All this equilibrium between the production and degradation of
the P2Y2 receptor is altered when a selective siRNA against the
P2Y2 mRNA is tested. When the siRNA starts it effect, there are still
receptors both in their way to degradation and from the Golgi to the
membrane. This fact produces a delay between the moment the siRNA
is applied to the moment when it is possible to see a decrease in the
P2Y2 expression. There is a mechanism of repression of the protein
synthesis that the epithelial cells try to resist, possibly by increasing
the synthesis of P2Y2-mRNA, but which is destroyed by the siRNA.
Nevertheless, when the ability of the oligonucleotide decreases, it
is possible that the overproduction of P2Y2-mRNA can start to
synthesize the protein reason by which we see an over-expression of
P2Y2 receptor 96 hours after the first siRNA instillation.
It is clear that more experiments should be done to confirm this
hypothesis and also it would be interesting to see whether or not this
effect is tissue selective or if this is a general feature of siRNA.
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